Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNION STAR METALS LTD Capital/Financing Update 2014

Aug 28, 2014

65987_rns_2014-08-28_0ef1bca9-f595-48b4-8ad1-b319bdae0364.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [36 x 159] intentionally omitted <==

==> picture [149 x 34] intentionally omitted <==

SOUTH AMERICA’S EMERGING PRECIOUS AND BASE METALS EXPLORER

Promesa Limited

Office Address

Suite 7 | 55 Hampden Rd, Nedlands, WA 6009 Australia

P: +61 8 9389 8884 F: +61 8 6389 0576

==> picture [161 x 181] intentionally omitted <==

ASX ANNOUNCEMENT

29 August 2014

Appendix 3B and Section 708A(5) Notice

Promesa Ltd (“Promesa” or the “Company”) is pleased to announce the issue of 31,354,545 ordinary shares for a total of $772,000. 3,500,000 were issued to under prior approval from shareholders gained in the General Meeting on 13 August. The Company advises a correction of the results of the Share Purchase Plan (SPP) announced yesterday, audit has shown that a total of 27,400,000 shares were accepted under the SPP, raising $685,000. The Company has also today issued 454,545 fully paid ordinary shares to a consultant of the company under a personal offer (as described in Section 708 of the Corporations Act 2001 (Corporations Act) from its 15% capacity pursuant to Listing Rule 7.1.

The Corporations Act restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A. By the Company giving this notice, sale of the Securities noted above will fall within the exemption in section 708A(5) of the Corporations Act.

The Company hereby notifies under section 708A(5)(e) of the Corporations Act that:

  • (a) the Securities were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

  • (b) as at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Corporations Act as they apply to the Company;

  • (c) as at the date of this notice, the Company has complied with section 674 of the Corporations Act as it applies to the Company; and

  • (d) as at the date of this notice, there is no information:

Contact

Ananda Kathiravelu Executive Director E: [email protected] M: +61 412 036 789

Michael Sebbag Executive Technical Director E: [email protected] M: +61 407 703 899

  • i. that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

  • ii. that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

  • A. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

  • B. The rights and liabilities attaching to the Securities.

ASX:PRA | PROMESA.COM.AU

Page 1

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

PROMESA LIMITED

ABN

36 124 541 466

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
3
Principal terms of the+securities
(e.g. if options, exercise price
and expiry date; if partly paid
+securities,
the
amount
outstanding and due dates for
payment;
if
+convertible
securities, the conversion price
and dates for conversion)
1. Ordinary Shares (PRA)
2. Ordinary Shares (PRA)
3. OrdinaryShares(PRA)
1. 27,400,000 pursuant to Share Purchase Plan
2. 3,500,000 pursuant to Res3 of 13 Aug GM
3. 454,545 pursuant to LR 7.1
1. fully paid
2. fully paid
3. fully paid
4
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
• the extent to which they do not rank
equally, other than in relation to the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
6a
Is the entity an+eligible entity that has
obtained security holder approval under
rule 7.1A?
If Yes, complete sections 6b – 6h_in_
relation to the+securities the subject of
this Appendix 3B, and comply with
section 6i
6b
The date the security holder resolution
under rule 7.1A was passed
6c
Number of+securities issued without
security holder approval under rule 7.1
6d
Number of
+securities issued with
security holder approval under rule 7.1A
6e
Number of
+securities issued with
security holder approval under rule 7.3,
or another specific security holder
approval (specify date of meeting)
6f
Number of+securities issued under an
exception in rule 7.2
The shares rank equally with existing shares.
1. $0.025
2. $0.022
3. $0.022
1. 27,400,000 pursuant to Share Purchase Plan
as announced 6 August 2014
2. 3,500,000 pursuant to Res #3 of 13 Aug GM
3. 454,545 pursuant to LR 7.1 for working
capital
Yes.
22 November 2013
454,545
NIL
3,500,000
27,400,000
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

6g If[+] securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

6h If[+] securities were issued under rule N/A 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

  • 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements

  • 7 +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

  • 8 Number and[+] class of all[+] securities quoted on ASX ( including the +securities in section 2 if applicable)

See Annexure 1 1. 29 August 2014 2. 29 August 2014 3. 29 August 2014 Number +Class 287,762,465 Fully paid ordinary shares.

9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
34,166,667
20,000,000
1,000,000
1,000,000
1,000,000
750,000
750,000
750,000
Unlisted Options
($0.05 Expiry 27
February 2016)
Unlisted Options
($0.05 Expiry 10
December 2015)
Unlisted Class A
Options ($0.15 Expiry
12 December 2014)
Unlisted Class B
Options ($0.20 Expiry
12 December 2014)
Unlisted Class C
Options ($0.25 Expiry
12 December 2014)
Unlisted Class A
Employee Options
($0.15 Expiry 24 June
2015)
Unlisted Class B
Employee Options
($0.20 Expiry 24 June
2015)
Unlisted Class C
Employee Options
($0.25 Expiry 24 June
2015)
The Directors do not anticipate declaring a
dividend in the foreseeable future.
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Part 2 - Pro rata issue

11 Is
security
holder
approval
required?
12 Is the issue renounceable or non-
renounceable?
13 Ratio in which the+securities
will be offered
14 +Class of+securities to which the
offer relates
15 +Record
date
to
determine
entitlements
16 Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing
date
for
receipt
of
acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee
or commission
22 Names of any brokers to the
issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25 If the issue is contingent on
security holders’ approval, the
date of the meeting
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27 If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do security holders sell
their entitlements_in full_through
a broker?
31 How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32 How do security holders dispose
of their entitlements (except by
sale through a broker)?
33 +Issue date
  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

  • 1 - 1,000

  • 1,001 - 5,000

  • 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

  • 38 Number of[+] securities for which +quotation is sought

  • 39 +Class of +securities for which quotation is sought

  • 40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities?

If the additional[+] securities do not rank equally, please state:

  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class

  • 42 Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Quotation agreement

  • 1 Quotation of our additional securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ......................................................... Date: 29 August 2014....... Company secretary

Print name: Damon Sweeny............................................... == == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

  • Insert number of fully paid[+] ordinary 133,083,133 securities on issue 12 months before the + issue date or date of agreement to issue Add the following: • Number of fully paid[+] ordinary securities 27,400,000 (this issue – SPP) issued in that 12 month period under an exception in rule 7.2

  • • Number of fully paid[+] ordinary securities 126,824,787 issued in that 12 month period with shareholder approval

  • • Number of partly paid[+] ordinary Nil securities that became fully paid in that 12 month period

  • Note: • Include only ordinary securities here – other classes of equity securities cannot be added

  • • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

  • Subtract the number of fully paid[+] ordinary - securities cancelled during that 12 month period “A” 287,307,920

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 43,096,188
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
454,545 (this issue)
“C” 454,545
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
43,096,188
Subtract“C”
Note: number must be same as shown in
Step 3
454,545
Total[“A” x 0.15] – “C” 42,641,643
[Note: this is the remaining placement
capacity under rule 7.1]
“C”
454,545
“C”
454,545
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 43,096,188
Note: number must be same as shown in
Step 2
Subtract“C” 454,545
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C” 42,641,643
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 287,307,920 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 28,730,792

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued NIL in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

“E” NIL

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in Step 2
28,730,792
Subtract“E”
Note: number must be same as shown in Step 3
NIL
Total[“A” x 0.10] – “E =remaining placement
capacity under rule 7.1A
28,730,792
  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013